-
-
GLP-1 Side Chains
显示更多 -
Peptide Intermediates
-
Fmoc-His-Aib-OH
-
Fmoc-Ile-Aib-OH
-
Fmoc-Tyr(tBu)-Aib-OH
-
Fmoc-Glu(OtBu)-Aib-OH
-
Fmoc-His(Fmoc)-Aib-OH
-
Fmoc-His(Fmoc)-Aib-OSu
显示更多 -
-
Tirzepatide Fragments
-
CAS:2682040-93-1
-
CAS:3034670-52-2
-
CAS:2656383-23-0
-
CAS:2461524-68-3
-
CAS:2656383-24-1
-
CAS:2656383-25-2
显示更多 -
-
API & Excipients
显示更多 -
Cosmetic Peptides
-
Oligopeptide-1
-
NonaPeptide-1
-
Copper Tripeptide-1
-
Acetyl Hexapeptide-8
-
Palmitoyl Tripeptide-1
-
Decarboxy Carnosine HCl
显示更多 -
-
Active Ingredients
显示更多
-
CPHI China 2025 | Congen pharma invites you to Shanghai to participate CPHI Shanghai
Publish Time:
2025-06-02

Exhibition Introduction
From June 24th to 26th, 2025, the 23rd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2025) will be grandly held at the Shanghai New International Expo Center. With over 3500 exhibitors, 230,000 square meters of exhibition space, and over 100,000 professional visitors from home and abroad, global wisdom will converge here to build a new ecosystem for the pharmaceutical industry!

Congen pharma is committed to making sustainable and affordable peptides accessible for human beauty and health. We provide the industry with various innovative processes and quality research services for pharmaceutical peptides, and supply side chains, peptide fragments, and oral enhancers with quality and price advantages. We will be exhibiting EMPHASES ® new liquid-phase peptide synthesis technology platform and GLP-1 (semaglutide, tirzepatide, etc.) series products. We look forward to your visit to booth E11D23 for discussions and participation!
We sincerely invite you to visit E11D23
↓↓↓

EMPHASES ® -Globally Innovative & Green and Efficient
Using liquid-phase carriers to replace traditional solid-phase resins improves reaction speed, shortens reaction time, and increases synthesis efficiency; reduces the use of amino acids, condensing agents, and solvents, reducing three wastes emissions, effectively controlling costs. To date, it has obtained 5 Chinese invention patents, 1 US invention patent, and 1 Japanese invention patent.

GLP-1 (Semaglutide, Tirzepatide) Industry Chain


Relevant Information
undefined
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home

